Endpoints News 2026-02-21 Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more
Endpoints News 2026-02-19 J&J pauses patient recruitment in mid-stage trial of AC Immune’s Alzheimer’s drug